Recombinant multi-species BSAP/PAX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BSAP/PAX5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the paired box (PAX) family of transcription factors. The central feature of this gene family is a novel, highly conserved DNA-binding motif, known as the paired box. Paired box transcription factors are important regulators in early development, and alterations in the expression of their genes are thought to contribute to neoplastic transformation. This gene encodes the B-cell lineage specific activator protein that is expressed at early, but not late stages of B-cell differentiation. Its expression has also been detected in developing CNS and testis and so the encoded protein may also play a role in neural development and spermatogenesis. This gene is located at 9p13, which is involved in t(9;14)(p13;q32) translocations recurring in small lymphocytic lymphomas of the plasmacytoid subtype, and in derived large-cell lymphomas. This translocation brings the potent E-mu enhancer of the IgH gene into close proximity of the PAX5 promoter, suggesting that the deregulation of transcription of this gene contributes to the pathogenesis of these lymphomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]
The Alternative Names of target: ALL3,B-cell-specific transcription factor (BSAP),BSAP,EBB-1,KLP,PAX-5,PAX5,Paired box protein Pax-5,Pax-5,Pax5,RGD1565236
Go
to BSAP/PAX5 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T29818-Ag-1/ GM-Tg-hg-T29818-Ag-2 | Human BSAP/PAX5 protein | Human |
| GM-Tg-rg-T29818-Ag-1/ GM-Tg-rg-T29818-Ag-2 | Rat BSAP/PAX5 protein | Rat |
| GM-Tg-mg-T29818-Ag-1/ GM-Tg-mg-T29818-Ag-2 | Mouse BSAP/PAX5 protein | Mouse |
| GM-Tg-cynog-T29818-Ag-1/ GM-Tg-cynog-T29818-Ag-2 | Cynomolgus/Rhesus macaque BSAP/PAX5 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T29818-Ag-1/ GM-Tg-felg-T29818-Ag-2 | Feline BSAP/PAX5 protein | Feline |
| GM-Tg-cang-T29818-Ag-1/ GM-Tg-cang-T29818-Ag-2 | Canine BSAP/PAX5 protein | Canine |
| GM-Tg-bovg-T29818-Ag-1/ GM-Tg-bovg-T29818-Ag-2 | Bovine BSAP/PAX5 protein | Bovine |
| GM-Tg-equg-T29818-Ag-1/ GM-Tg-equg-T29818-Ag-2 | Equine BSAP/PAX5 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T29818-Ag-1/ GM-Tg-hg-T29818-Ag-2;
GM-Tg-rg-T29818-Ag-1/ GM-Tg-rg-T29818-Ag-2;
GM-Tg-mg-T29818-Ag-1/ GM-Tg-mg-T29818-Ag-2; GM-Tg-cynog-T29818-Ag-1/ GM-Tg-cynog-T29818-Ag-2; GM-Tg-felg-T29818-Ag-1/ GM-Tg-felg-T29818-Ag-2; GM-Tg-cang-T29818-Ag-1/ GM-Tg-cang-T29818-Ag-2; GM-Tg-bovg-T29818-Ag-1/ GM-Tg-bovg-T29818-Ag-2; GM-Tg-equg-T29818-Ag-1/ GM-Tg-equg-T29818-Ag-2 |
| Products Name | BSAP/PAX5 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | BSAP/PAX5 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine BSAP/PAX5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.